ALDH3A1in vitroIncreased resistance: 4-hydroxyperoxycyclophosphamide, doxorubicin, etoposide, 5-FU, γ-ray, H2O2 [
72]CATin vitroIncreased resistance: UVB [
73], benzo(a)pyrene [
74], paraquat [
81], H2O2 [
83,
89,
90,
91], benzyl isothiocyanate [
84], dexamethasone [
86], temozolomide, γ-ray, staurosporine [
88], combination of ascorbate and menadione [
90]
Unchanged resistance: γ-ray [
82], paraquat, TBHP [
83], TNF-alpha [
85], γ-ray, 5-FU, cisplatin, doxorubicin [
90]
Decreased resistance: Cr (VI) [
87], paclitaxel, etoposide, arsenic trioxide, aminotriazol [
90]in vivoIncreased resistance: benzo(a)pyrene [
75,
76], H2O2 [
77], doxorubicin [
78], proton radiation [
79,
80]
Unchanged resistance: γ-ray [
82]SOD1 +
CATin vivoIncreased resistance: benzo(a)pyren [
75]GCLCin vitroIncreased resistance: γ-ray [
93], UVC [
94], tamoxifen [
95]in vivoIncreased resistance: paraquat [
92]GCLC+
GCLMin vitroIncreased resistance: γ-ray [
93]GCLMin vitroIncreased resistance: γ-ray [
93]GPX1in vitroIncreased resistance: UVB [
96], deoxynivalenol [
97], cisplatin [
99,
103,
105], X-ray [
100], doxorubicin [
106], H2O2, GSH high concentration [
107]
Decreased resistance: cisplatin [
103], gemcitabine [
104]in vivoIncreased resistance: ischemia-reperfusion injury [
98], cocaine [
101], microcystin-leucine-arginine [
102]GPX2in vitroIncreased resistance: cisplatin [
108]GPX3in vitroIncreased resistance: ascorbate [
109], cisplatin [
110], NAPQI [
111]GPX4in vitroIncreased resistance: hypericin + PDT [
112], TBHP [
113], H2O2, erastin [
114], AAPH, 5-HPETE [
115], staurosporine, etoposide, UVB, actinomycin D, cycloheximide [
116]
Unchanged resistance: etoposide [
113], calcium ionophore A23187 [
116]GSRin vitroIncreased resistance: temozolomide, cisplatin [
117], H2O2 [
118]GSTP1in vitroIncreased resistance: hypericin+PDT [
112]mt-PRDX5in vitroIncreased resistance: H2O2 [
119] mt-SOD1in vitroIncreased resistance: γ-ray [
51]mt-CATin vitroIncreased resistance: γ-ray [
82]mt-CAT + SOD2in vitroIncreased resistance: γ-ray [
82]MTIin vitroIncreased resistance: TBHP, CdCl2 [
120], Zn(II) [
121]
Unchanged resistance: alkylating agents [
121]MTIIin vitroIncreased resistance: MNU, MNNG [
122], cisplatin, melphalan, chlorambucil [
123], streptozotocin [
124]
Unchanged resistance: bleomycin [
122,
123], γ-ray, MMS, N-hydroxyethyl N-chloroethylnitrosourea [
122], 5-FU, vincristine, doxorubicin [
123]NFE2L2in vitroIncreased resistance: UVA+UVB [
125], cisplatin [
126,
128,
129,
130], 5-FU [
126,
130], γ-ray [
126], TBHP [
127], X-ray [
73], tamoxifen [
131], gemcitabine [
132]NQO1in vitroIncreased resistance: tamoxifen [
95]nuclear-PRDX5in vitroUnchanged resistance: H2O2 [
119]PON1in vitroIncreased resistance: 5-fluorouracil, paclitaxel, cisplatin, etoposide [
133], streptozotocin (mouse model of diabetes) [
138] in vivoIncreased resistance: arthritis induction (K/BxN serum transfer (STIA) or collagen antibody transfer (CAIA) to mice [
134], carbon tetrachloride [
135,
137], elastase-induced abdominal aortic aneurysm [
136]PON2in vitroIncreased resistance: y-ray [
139], tert-butyl-hydroperoxide [
140], cisplatin [
141], dexamethasone [
142], oxygen-glucose deprivation/reoxygenation exposure [
143], Nε-(carboxymethyl) lysine [
144], pyocyanin [
145], hypoxia [
146], 2,3-dimethoxy-1,4-naphthoquinone [
148]
Unchanged resistance: dacarbazine [
141]in vivoIncreased resistance: dexamethasone [
142], apolipoprotein E deficiency [
147]PON3in vivoIncreased resistance: carbon tetrachloride [
135,
149]PRDX1in vitroIncreased resistance: thiosemicarbazone iron chelator triapine [
150], glucose oxidase [
151], BCNU [
62], γ-ray [
65,
152], 6-hydroxydopamine [
152], doxorubicin [
154]PRDX2in vitroIncreased resistance: H2O2 [
58,
155], γ-ray [
156], 6-hydroxydopamine [
153], doxorubicin [
154]in vivoIncreased resistance: 6-hydroxydopamine [
153], ischemia [
176]PRDX3in vitroIncreased resistance: H2O2 [
157], doxorubicin [
154], arsenic trioxide [
158]
Unchanged resistance: 6-hydroxydopamine [
153]PRDX4in vitroIncreased resistance: γ-ray [
66], urethane [
159], photon radiation [
160], 6-hydroxydopamine [
153]
Unchanged resistance: doxorubicin [
154]PRDX5in vitroIncreased resistance: H2O2 [
161,
162,
165], TBHP [
162], MPP+ [
163], adriamycin, etoposide [
164], menadione, cigarette smoke extract [
165], shikonin [
166], emodin [
167], β-Lapachone [
168], doxorubicin [
154]PRDX6in vitroIncreased resistance: cisplatin [
169], doxorubicin [
170], hypoxia, cobalt chloride [
171], UVA, menadione [
172], H2O2 [
173], X-ray [
175]
Decreased resistance: TNF-α/CHX solution [
173]in vivoIncreased resistance: UVA, UVB [
172], urethane [
174]SLC31A1in vitroIncreased resistance: paraquat [
177]SLC7A11in vitroIncreased resistance: cisplatin [
178], temozolomide [
179]SOD1in vitroIncreased resistance: γ-ray [
181,
183], S-nitroso-N-acetylpenicillamine, spermine-NONOate, diethylamine-NONOate [
182], paraquat [
83,
177], cisplatin [
186,
187], docosahexaenoic acid [
188], xanthine oxidase, hypoxanthine, menadione [
189], TBHP [
83], benzyl isothiocyanate [
84], TNF and hyperthermia [
190], Bortezomib [
191], phenazine methosulfate [
192]
Unchanged resistance: γ-ray [
51,
180,
193], N-methyl-D-aspartate, kainic acid, glutamate [
182], H2O2 [
83,
182], UVB [
73]
Decreased resistance: menadione [
182], Cr (VI) [
87]in vivoIncreased resistance: paraquat, γ-ray [
184], benzo(a)pyrene [
75,
76]
Unchanged resistance: hyperoxia, paraquat [
185]SOD1 + CATin vitroIncreased resistance: paraquat, H2O2 [
83], UVB [
73]
Unchanged resistance: TBHP [
83]SOD2in vitroIncreased resistance: paraquat [
180], γ-ray [
51,
82,
181,
195,
196,
203,
205,
206], cisplatin [
194,
201], X-ray [
197], doxorubicin [
198,
200], docetaxel [
200], 2-methoxyestradiol [
202], glutamate [
56], TNF- alpha [
85], H2O2 [
204], menadione, epirubicin [
207]
Unchanged resistance: γ-ray [
193,
206]
Decreased resistance: Cr (VI) [
87]in vivoIncreased resistance: γ-ray [
51,
82]
Unchanged resistance: 100% O2 [
199]mt-signal deleted SOD2in vitroUnchanged resistance: γ-ray [
51]SOD2 + CATin vitroUnchanged resistance: TNF-alpha [
85] SOD3in vitroIncreased resistance: H2O2 [
211]in vivoIncreased resistance: 4-MV photon radiation [
208], ischemia [
209], 12-O-tetradecanoylphorbol-13-acetate [
210], lipopolysaccharide induced endotoxemia [
20]TXNin vitroIncreased resistance: H2O2 [
212,
220,
224], daunomycin [
213], MPP+ [
215], menadione, 1-chloro-2,4-dinitrobenzene [
71], arsenic trioxide [
222,
223]
Unchanged resistance: dexamethasone, doxorubicin, etoposide [
220], auranofin, juglone [
71]in vivoIncreased resistance: methamphetamine [
214,
221], sepsis-induced myocardial dysfunction, sham surgery [
216], ischemia [
217,
225], ex vivo ischemia [
218], adriamycin [
219]TXNL1in vitroDecreased resistance: cisplatin [
226]TXNRD1in vitroIncreased resistance: X-ray [
227], H2O2 [
224]
留言 (0)